A Pilot Study of Pembrolizumab and Neoadjuvant Radiation for Large, High-Risk Soft Tissue Sarcomas
Phase: PHASE1
Conditions: Soft Tissue Sarcoma, Recurrent Soft Tissue Sarcoma
Sponsor: Fred Hutchinson Cancer Center



	

	 
 i 	
	

A

ouuuyfdf
	


		



	

toPttPSoSu